TAP-ing into TIEPPs for cancer immunotherapy

The Journal of Clinical Investigation
R Kiessling

Abstract

Cancer immunotherapy in which cytotoxic T cells (CTLs) target tumor-specific antigens complexed to MHC-I molecules has been used successfully for several types of cancer; however, MHC-I is frequently downregulated in tumors, resulting in CTL evasion. Recently, it has been shown that MHC-Ilo tumors produce a set of T cell epitopes associated with impaired peptide processing (TEIPP) that have potential to be exploited for immunotherapy. TEIPP-specific CTLs recognize tumors defective in antigen presentation machinery (APM) but not those with intact APM. In this issue of the JCI, Doorduljn et al. evaluated thymus selection and peripheral behavior of TEIPP-specific T cells, using a unique T cell receptor (TCR) transgenic mouse model. They demonstrated that TEIPP-specific T cells in TAP-deficient mice have largely been deleted by central tolerance, while the same T cells in WT mice are naive and sustained. The results of this study suggest that TIEPPs have potential to be successful targets for elimination of MHC-Ilo tumors.

References

Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·E Z WolpertK Kärre
Apr 3, 2002·Seminars in Cancer Biology·Barbara SeligerSoldano Ferrone
Mar 22, 2006·Nature Medicine·Thorbald van HallRienk Offringa
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thorbald van HallEmmanuel J H J Wiertz
May 1, 2008·European Journal of Immunology·Andreas O WeinzierlStefan Stevanović
Oct 29, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Margit H LampenThorbald van Hall
Nov 26, 2011·Cancer Immunology, Immunotherapy : CII·Ursula J E SeidelThorbald van Hall
May 19, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Bradley J SeamanH Jeffrey Kim
Feb 5, 2013·Journal of Immunotherapy·Richard A MorganSteven A Rosenberg
Apr 13, 2013·Current Opinion in Immunology·Helen Angell, Jérôme Galon
Feb 15, 2014·World Journal of Clinical Cases·Federico GobbiZeno Bisoffi
Oct 15, 2014·Nature Reviews. Clinical Oncology·Steven A Rosenberg
Jan 20, 2016·The Journal of Clinical Investigation·Elien M DoorduijnThorbald van Hall

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.